Ani Pharmaceuticals ANIP Peer Comparison

NASDAQ ANIP
$70.65 +0.42 (+0.60%)
As of: Sep 9, 2026 · 12:04 PM EDT
Peer Comparison

247 Comparable Companies

Industry Generic Drugs

Ani Pharmaceuticals Inc (ANIP) is the 79th largest of 247 Generic Drugs companies by market capitalisation, at 1.50 Bn, behind Innoviva, Inc. at 1.54 Bn. It trades on a P/E of 13.88, 15% below the peer median of 16.26. The table below compares all 247 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 TEVA Teva Pharmaceutical Industries Ltd primary H-04 Pharmaceuticals and Biotechnology HG-01 42.93 Bn 61.68 2.48 39.28 Bn
2 VTRS Viatris Inc primary H-04 Pharmaceuticals and Biotechnology HG-01 19.25 Bn -46.86 1.31 18.36 Bn
3 RDY Dr Reddys Laboratories Ltd primary H-04 Pharmaceuticals and Biotechnology HG-01 9.86 Bn 781.50 2.69 9.69 Bn
4 AMRX Amneal Pharmaceuticals, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 5.52 Bn 25.65 1.77 5.39 Bn
5 BHC Bausch Health Companies Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -2.18 0.22 0.55 Bn
6 ANIP Ani Pharmaceuticals Inc primary H-04 Pharmaceuticals and Biotechnology HG-01 1.50 Bn 13.88 1.53 1.14 Bn
7 ALVO Alvotech primary H-04 Pharmaceuticals and Biotechnology HG-01 1.49 Bn -5.36 4.35 1.35 Bn
8 AMPH Amphastar Pharmaceuticals, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 1.00 Bn 11.94 1.36 0.71 Bn
9 FENC Fennec Pharmaceuticals Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -92.67 7.65 0.37 Bn
10 RDHL RedHill Biopharma Ltd. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -434.89 37.17 0.18 Bn
11 NTRB NutriBand Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -10.07 43.36 0.07 Bn
12 BGM BGM Group Ltd. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.03 Bn — — 0.02 Bn
13 ETST Earth Science Tech, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 6.76 0.72 0.02 Bn
14 NXPL NextPlat Corp primary H-04 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.48 0.51 0.01 Bn
15 COSM Cosmos Health Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.77 0.21 0.01 Bn
16 SCNX Scienture Holdings, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.89 34.79 0.01 Bn
17 AEON AEON Biopharma, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.25 — 0.01 Bn
18 PMHS Polomar Health Services, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.59 1.78 0.01 Bn
19 SXTP 60 Degrees Pharmaceuticals, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.39 2.28 0.00 Bn
20 SBFM Sunshine Biopharma Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.26 0.04 -0.01 Bn
21 QNRX Quoin Pharmaceuticals, Ltd. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — 0.00 Bn
22 PRFX PRF Technologies Ltd. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.18 53.74 -0.01 Bn
23 GRMLW Greenland Mines Ltd primary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.02 — -0.01 Bn
24 JNJ Johnson & Johnson secondary H-01 Pharmaceuticals and Biotechnology HG-01 647.54 Bn 30.78 6.61 626.78 Bn
25 ABBV AbbVie Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 441.45 Bn 69.89 6.86 434.88 Bn
26 MRK Merck & Co., Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 364.78 Bn 115.11 5.48 357.64 Bn
27 NVS Novartis Ag secondary H-01 Pharmaceuticals and Biotechnology HG-01 267.01 Bn 9.27 3.89 259.32 Bn
28 ABT Abbott Laboratories secondary H-06 Medical Devices and Diagnostics HG-02 184.57 Bn 34.02 3.96 178.97 Bn
29 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 181.55 Bn -62.71 5.96 178.37 Bn
30 PFE Pfizer Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 158.95 Bn 36.39 2.50 147.25 Bn
31 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 132.31 Bn 30.03 10.51 124.45 Bn
32 SNY Sanofi secondary H-01 Pharmaceuticals and Biotechnology HG-01 52.54 Bn 11.27 0.98 45.16 Bn
33 RVMD Revolution Medicines, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 44.23 Bn -25.01 — 44.23 Bn
34 ALC Alcon Inc secondary H-06 Medical Devices and Diagnostics HG-02 33.97 Bn 52.83 3.16 32.51 Bn
35 BIIB Biogen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 31.41 Bn 37.63 3.13 30.12 Bn
36 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 30.10 Bn -20.28 2,755.62 30.10 Bn
37 GEHC GE HealthCare Technologies Inc. secondary H-08 Medical Devices and Diagnostics HG-02 29.92 Bn 14.59 1.41 27.81 Bn
38 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.83 Bn -31.80 24.46 26.67 Bn
39 INCY Incyte Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 25.36 Bn 15.73 4.36 20.82 Bn
40 UTHR UNITED THERAPEUTICS Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 21.31 Bn 16.26 6.76 18.65 Bn
41 NBIX Neurocrine Biosciences Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.53 Bn 22.02 4.60 15.15 Bn
42 JAZZ Jazz Pharmaceuticals plc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.13 Bn 16.08 3.29 13.51 Bn
43 BWXT BWX Technologies, Inc. secondary I-39 Clean Energy Equipment IG-10 14.48 Bn 40.67 4.12 13.88 Bn
44 EXEL Exelixis, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 14.41 Bn 16.75 5.92 13.57 Bn
45 BAX Baxter International Inc secondary H-07 Medical Devices and Diagnostics HG-02 12.81 Bn 557.12 1.15 10.66 Bn
46 CORT Corcept Therapeutics Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 12.29 Bn 226.82 14.80 11.99 Bn
47 KYMR Kymera Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 11.40 Bn -38.04 108.54 10.71 Bn
48 AXSM Axsome Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 10.88 Bn -70.79 14.01 10.56 Bn
49 GKOS GLAUKOS Corp secondary H-06 Medical Devices and Diagnostics HG-02 10.68 Bn -67.82 17.43 10.57 Bn
50 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.20 Bn -26.74 — 9.44 Bn
51 NUVL Nuvalent, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 9.75 Bn -27.07 — 9.75 Bn
52 CYTK Cytokinetics Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 9.74 Bn -13.28 143.91 8.57 Bn
53 GPCR Structure Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 9.41 Bn -50.01 — 9.41 Bn
54 CRNX Crinetics Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 8.99 Bn -17.90 213.22 8.99 Bn
55 ALKS Alkermes plc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 7.59 Bn 114.81 4.55 6.94 Bn
56 BLCO Bausch & Lomb Corp secondary H-06 Medical Devices and Diagnostics HG-02 6.43 Bn -39.46 1.21 6.05 Bn
57 HIMS Hims & Hers Health, Inc. secondary H-16 Healthcare Providers HG-04 6.37 Bn -44.82 2.47 5.53 Bn
58 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.30 Bn -703.30 4,524.98 6.30 Bn
59 BLTE Belite Bio, Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 6.21 Bn 0.08 — 6.21 Bn
60 TVTX Travere Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 6.18 Bn -142.29 10.46 6.07 Bn
61 LQDA Liquidia Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 6.09 Bn 43.92 13.50 5.80 Bn
62 AMRN Amarin Corp Plc\Uk secondary H-01 Pharmaceuticals and Biotechnology HG-01 5.96 Bn -219.55 31.98 5.64 Bn
63 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.04 Bn -17.55 — 5.04 Bn
64 FMCQF Fresenius Medical Care AG secondary H-14 Healthcare Providers HG-04 4.79 Bn 4.57 0.17 4.09 Bn
65 ACAD Acadia Pharmaceuticals Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 4.78 Bn 12.55 4.19 3.82 Bn
66 EWTX Edgewise Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 4.66 Bn -23.64 — 4.66 Bn
67 DFTX Definium Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 4.20 Bn -11.88 — 4.20 Bn
68 INDV Indivior Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 4.05 Bn 11.41 3.04 3.83 Bn
69 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.02 Bn -7.86 1,115.68 4.02 Bn
70 MANE Veradermics, Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 4.01 Bn -46.57 — 4.01 Bn
71 CPRX CATALYST PHARMACEUTICALS, INC. secondary H-01 Pharmaceuticals and Biotechnology HG-01 3.85 Bn 17.94 6.45 3.09 Bn
72 ELVN Enliven Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 3.85 Bn -45.72 — 3.85 Bn
73 TARS Tarsus Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 3.66 Bn -78.05 6.04 3.21 Bn
74 OGN Organon & Co. secondary H-01 Pharmaceuticals and Biotechnology HG-01 3.61 Bn 17.26 0.59 2.47 Bn
75 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.58 Bn -7.79 30.62 2.88 Bn
76 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.99 Bn -11.06 593.06 2.47 Bn
77 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.92 Bn -8.55 79.36 2.47 Bn
78 NAMS NewAmsterdam Pharma Co N.V. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.90 Bn -11.17 407.13 2.90 Bn
79 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.83 Bn -15.03 6.29 2.12 Bn
80 CURLF Curaleaf Holdings, Inc. secondary S-09 Tobacco and Cannabis SG-04 2.72 Bn -22.95 2.08 2.63 Bn
81 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.63 Bn -81.01 — 2.63 Bn
82 MLYS Mineralys Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.62 Bn -7.51 — 2.62 Bn
83 TAK Takeda Pharmaceutical Co Ltd secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.62 Bn 4.56 0.06 -3.18 Bn
84 TRVI Trevi Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.61 Bn -61.82 — 2.61 Bn
85 BEIGF BeOne Medicines Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.48 Bn 3.74 0.40 -2.62 Bn
86 SUPN Supernus Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.44 Bn -28.61 3.09 2.06 Bn
87 HRMY Harmony Biosciences Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.43 Bn 13.64 2.53 1.63 Bn
88 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.31 Bn -5.99 4.31 1.95 Bn
89 NUVB Nuvation Bio Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.29 Bn -21.22 13.51 2.29 Bn
90 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.25 Bn -3.84 — 1.99 Bn
91 PVLA Palvella Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.19 Bn -41.35 — 1.88 Bn
92 AUPH Aurinia Pharmaceuticals Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.10 Bn 6.67 6.73 1.65 Bn
93 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.05 Bn -4.92 2,045.15 2.05 Bn
94 ETON Eton Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.64 Bn 171.80 16.36 1.61 Bn
95 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.54 Bn -9.11 20.12 1.26 Bn
96 INVA Innoviva, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.54 Bn 7.84 2.99 0.96 Bn
97 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.49 Bn -3.23 2.08 1.20 Bn
98 LBRX Lb Pharmaceuticals Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.46 Bn -24.09 — 1.46 Bn
99 XERS Xeris Biopharma Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.45 Bn -84.47 4.32 1.33 Bn
100 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn -8.68 — 1.42 Bn
101 HROW Harrow, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.41 Bn -42.26 5.13 1.33 Bn
102 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn 80.63 35.82 1.38 Bn
103 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -25.48 — 1.00 Bn
104 OPK Opko Health, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.19 Bn -31.29 2.02 0.88 Bn
105 OLMA Olema Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.11 Bn -5.42 — 1.11 Bn
106 KURA Kura Oncology, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.08 Bn -4.53 13.97 1.08 Bn
107 PCRX Pacira BioSciences, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 69.00 1.35 0.76 Bn
108 MNPR Monopar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -69.78 — 0.91 Bn
109 LXRX Lexicon Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -15.13 22.94 0.76 Bn
110 DSGN Design Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -11.76 — 0.74 Bn
111 SGP SpyGlass Pharma, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.93 Bn -48.72 — 0.93 Bn
112 ACRS Aclaris Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.84 Bn -10.51 101.77 0.84 Bn
113 VSTM Verastem, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.81 Bn -6.99 9.20 0.67 Bn
114 COLL Collegium Pharmaceutical, Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.77 Bn 16.02 0.95 0.62 Bn
115 PHAT Phathom Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.74 Bn -7.56 3.10 0.56 Bn
116 ZVRA Zevra Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.73 Bn 12.55 5.37 0.51 Bn
117 GYRE Gyre Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.71 Bn -38.37 5.93 0.65 Bn
118 IVEVF Inventiva S.A. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.69 Bn 7.19 132.94 0.69 Bn
119 CRMD CorMedix Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.64 Bn 5.09 1.71 0.38 Bn
120 AQST Aquestive Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -8.18 11.83 0.54 Bn
121 MPLT MapLight Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.62 Bn -3.07 — 0.62 Bn
122 OCS Oculis Holding AG secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -344,077.60 — 0.60 Bn
123 DCTH Delcath Systems, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.58 Bn 1,174.84 6.08 0.48 Bn
124 EOLS Evolus, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -16.63 1.80 0.53 Bn
125 NVCT Nuvectis Pharma, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.55 Bn -18.13 — 0.55 Bn
126 IRD Opus Genetics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.54 Bn -5.57 54.98 0.45 Bn
127 OVID Ovid Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.53 Bn -15.46 336.78 0.42 Bn
128 SPRY ARS Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -2.37 4.48 0.38 Bn
129 PRLD Prelude Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -7.58 22.77 0.23 Bn
130 ANL Adlai Nortye Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn -10.27 78.36 0.26 Bn
131 PALI Palisade Bio, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -12.61 889.92 0.32 Bn
132 XFOR X4 Pharmaceuticals, Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -4.91 27.94 0.25 Bn
133 IKT Inhibikase Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -6.46 — 0.26 Bn
134 TTRX Turn Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -53.83 — 0.41 Bn
135 VTVT vTv Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -85.61 11.05 0.41 Bn
136 EVMN Evommune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -4.26 40.29 0.20 Bn
137 SION Sionna Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -3.42 — 0.33 Bn
138 ACHV Achieve Life Sciences, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.33 Bn — — 0.33 Bn
139 VNDA Vanda Pharmaceuticals Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -1.15 1.46 0.15 Bn
140 SWKHL SWK Holdings Corp secondary F-06 Lending and Credit FG-02 0.31 Bn -332.76 7.48 0.27 Bn
141 IMRX Immuneering Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -5.12 — 0.30 Bn
142 EBS Emergent BioSolutions Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -1.66 0.38 0.15 Bn
143 FULC Fulcrum Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -3.25 — 0.29 Bn
144 ZNTL Zentalis Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -1.97 — 0.28 Bn
145 AKBA Akebia Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -8.88 1.20 0.11 Bn
146 CELG-RI Bristol Myers Squibb Co secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.02 0.00 -10.84 Bn
147 SIGA Siga Technologies Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn — — 0.07 Bn
148 TNXP Tonix Pharmaceuticals Holding Corp. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.35 7.42 0.22 Bn
149 FTH Faeth Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.09 — 0.21 Bn
150 DERM Journey Medical Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -57.60 3.09 0.18 Bn
151 CRDL Cardiol Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -7.78 — 0.20 Bn
152 ACOG Alpha Cognition Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -7.30 14.98 0.16 Bn
153 NERV Minerva Neurosciences, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -30.08 — 0.20 Bn
154 SLGL Sol-Gel Technologies Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -18.47 107.94 0.15 Bn
155 MCUJF Medicure Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -37.45 8.18 0.19 Bn
156 LONA LeonaBio, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -1.52 — 0.13 Bn
157 MENS Jyong Biotech Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -46.69 — 0.16 Bn
158 LENZ LENZ Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -1.24 7.47 0.16 Bn
159 TNYA Tenaya Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -1.42 109.36 0.15 Bn
160 IFRX InflaRx N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 1,818.12 -0.04 Bn
161 SPRB Spruce Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -2.88 — 0.14 Bn
162 BMEA Biomea Fusion, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -2.37 — 0.13 Bn
163 NRXP NRX Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -6.14 37.69 0.10 Bn
164 VANI Vivani Medical, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -4.27 — 0.10 Bn
165 VRCA Verrica Pharmaceuticals Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -3.44 3.57 0.10 Bn
166 AARD Aardvark Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -1.54 — 0.03 Bn
167 CPIX Cumberland Pharmaceuticals Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -8.98 3.10 0.09 Bn
168 TENX Tenax Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -1.48 — 0.10 Bn
169 CGTX Cognition Therapeutics Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -2.50 — 0.09 Bn
170 NTHI Neonc Technologies Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -2.04 — 0.09 Bn
171 MNOV Medicinova Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -7.59 99.85 0.09 Bn
172 PYPD PolyPid Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 2.70 — 0.08 Bn
173 PTHS Pelthos Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -0.76 1.57 0.06 Bn
174 FBIO Fortress Biotech, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 10.00 1.21 -0.11 Bn
175 RGC Regencell Bioscience Holdings Ltd secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.08 Bn — — 0.08 Bn
176 PMVP PMV Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.21 — -0.01 Bn
177 PLRX Pliant Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -0.77 — 0.07 Bn
178 AIFC AI Financial Corp secondary T-54 Fintech TG-09 0.07 Bn -0.08 3.44 0.06 Bn
179 BOLD Boundless Bio, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -1.00 — 0.06 Bn
180 VERU Veru Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 117.37 — 0.03 Bn
181 GOSS Gossamer Bio, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.30 0.96 -0.01 Bn
182 PTN Palatin Technologies Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -7.83 3.81 0.05 Bn
183 KPTI Karyopharm Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.25 0.33 -0.02 Bn
184 ANVS Annovis Bio, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.96 — 0.05 Bn
185 CLNN Clene Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.34 213.14 0.04 Bn
186 APRE Aprea Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -3.42 — 0.04 Bn
187 IXHL Incannex Healthcare Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.85 — 0.04 Bn
188 APLM Apollomics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -3.72 4.79 0.03 Bn
189 SCLX Scilex Holding Co secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.08 1.18 -0.08 Bn
190 GRCE Grace Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.85 — 0.04 Bn
191 CPHI China Pharma Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -7.57 8.66 0.03 Bn
192 BETRF BetterLife Pharma Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -21.82 — 0.04 Bn
193 UG United Guardian Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 14.56 2.94 0.02 Bn
194 ACTU Actuate Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.54 — 0.03 Bn
195 KAPA Kairos Pharma, LTD. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -6.19 0.38 0.03 Bn
196 NSRX Nasus Pharma Ltd secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -5.64 — 0.03 Bn
197 BYSI BeyondSpring Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.02 — 0.03 Bn
198 CRVO CervoMed Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.84 76.69 0.03 Bn
199 TXMD TherapeuticsMD, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -135.76 7.68 0.02 Bn
200 YARW Yarrow Bioscience, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.12 46.85 0.00 Bn
201 AYTU Aytu Biopharma, Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.75 0.40 0.00 Bn
202 ATOS Atossa Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.72 — 0.02 Bn
203 ALLR Allarity Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.68 814.63 0.02 Bn
204 BFRI Biofrontera Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -4.31 0.45 0.02 Bn
205 MIRA Mira Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.56 — 0.01 Bn
206 TVRD Tvardi Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.68 — 0.02 Bn
207 KPRX Kiora Pharmaceuticals Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.42 — 0.02 Bn
208 HIND Vyome Holdings, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.30 120.11 0.01 Bn
209 MDBH MDB Capital Holdings, LLC secondary F-17 Capital Markets FG-05 0.02 Bn -1.26 — 0.01 Bn
210 CTXR Citius Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.34 2.18 0.02 Bn
211 QCLS Q/C Technologies, Inc. secondary T-01 Semiconductors TG-01 0.01 Bn -2.05 — 0.01 Bn
212 ANEB Anebulo Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.64 — 0.01 Bn
213 RKTO Rocket One Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.04 — 0.01 Bn
214 INTI Inhibitor Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -3.67 — 0.01 Bn
215 MGRX Mangoceuticals, Inc. secondary H-16 Healthcare Providers HG-04 0.01 Bn -0.43 21.96 0.01 Bn
216 CALC CalciMedica, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.32 -8.02 -0.01 Bn
217 RVPH Reviva Pharmaceuticals Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.74 — 0.01 Bn
218 CURX Curanex Pharmaceuticals Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.88 — 0.00 Bn
219 ADXN Addex Therapeutics Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn 0.05 — 0.01 Bn
220 ACXP Acurx Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.81 — 0.01 Bn
221 PULM Pulmatrix, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.46 — 0.01 Bn
222 TRAW Traws Pharma, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.34 — 0.00 Bn
223 PCSA Processa Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.41 — 0.01 Bn
224 INM InMed Pharmaceuticals Inc. secondary M-02 Chemicals MG-01 0.01 Bn -0.66 — 0.00 Bn
225 TPST Tempest Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.25 — 0.00 Bn
226 TCRT Alaunos Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.94 1,276.64 0.00 Bn
227 BICX BioCorRx Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.64 6.70 0.00 Bn
228 CVKD Cadrenal Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.29 — 0.00 Bn
229 CASIF CASI Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.02 0.12 0.00 Bn
230 OGEN Oragenics Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.23 — 0.00 Bn
231 BTAI BioXcel Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.03 2.95 0.00 Bn
232 UPC Universe Pharmaceuticals INC secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — -1,490.23 Bn
233 CANF Can-Fite BioPharma Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.24 5.93 0.00 Bn
234 ENSC Ensysce Biosciences, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — 0.00 Bn
235 MTNB Matinas BioPharma Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.16 — 0.00 Bn
236 SKVI Skinvisible, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.05 54.04 0.00 Bn
237 SPRC SciSparc Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.05 0.76 0.00 Bn
238 NCEL NewcelX Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.06 — 0.00 Bn
239 GLMD Galmed Pharmaceuticals Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — 0.00 Bn
240 FCHS First Choice Healthcare Solutions, Inc. secondary H-14 Healthcare Providers HG-04 0.00 Bn -0.05 — 0.00 Bn
241 CDT CDT Equity Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.01 — 0.00 Bn
242 JAGX Jaguar Health, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.01 0.01 -0.01 Bn
243 GCAN Trafalgar International, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.77 — 0.00 Bn
244 CINGW Cingulate Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 — 0.00 Bn
245 ZCMD Zhongchao Inc. secondary T-27 Vertical Software TG-05 0.00 Bn -0.01 0.00 -0.01 Bn
246 SXTC China SXT Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 0.03 -0.03 Bn
247 CMND Clearmind Medicine Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 — -0.01 Bn